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ABSTRACT 26 
Antimicrobial peptides derived from food proteins constitute a new field in the 27 
combined use of antimicrobial agents in food. The best examples of milk-derived 28 
peptides are those constituted by bovine lactoferricin [lactoferrin f(17-41)] (LFcin-B) 29 
and bovine αs2-casein f(183-207). The aim of this work was to study if the antimicrobial 30 
activity of a natural compound employed in food preservation, nisin, could be enhanced 31 
by combination with the afore-mentioned milk-derived peptides. Furthermore, the 32 
possibility of a synergistic effect between these peptides and bovine lactoferrin (LF) 33 
against Escherichia coli and Staphylococcus epidermidis was also studied. Finally, the 34 
most active combinations were assayed against the food-borne pathogens Listeria 35 
monocytogenes and Salmonella choleraesuis. Results showed a synergistic effect when 36 
LFcin-B was combined with bovine LF against E. coli. In the same way, the 37 
combination of LFcin-B with bovine LF was synergistic against St. epidermidis. Bovine 38 
LF and nisin increased their antimicrobial activity when they were assayed together 39 
with bovine αs2-casein f(183-207). It is important to note the synergistic effect among 40 
LFcin-B and bovine LF, as both compounds might be simultaneously in the suckling 41 
gastrointestinal tract, and could, therefore, have a protective effect on it. The other 42 
synergistic effect highlighted is that between αs2-casein f(183-207) and nisin against L. 43 
monocytogenes because of the ability of L monocytogenes to develop resistance to nisin. 44 
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INTRODUCTION 47 
Food preservation procedures such as pasteurization, refrigeration, canning, 48 
modified atmosphere packaging or the incorporation of chemical preservatives in food 49 
are usually employed to prevent the growth of bacteria that may cause human disease or 50 
food spoilage. Chemical preservatives such as benzoates, sorbates, nitrites and sulphites 51 
have been used effectively, but their safety is continually under study (Knekt et al., 52 
1999; McCann et al., 2007). The consumer demand for minimally processed foods has 53 
led to the search for biopreservatives that can be safely incorporated into various food 54 
products. Although numerous studies have shown the effectiveness of biopreservatives 55 
against microorganisms (Altieri et al., 2005; Schnurer and Magnusson, 2005), some of 56 
them have a limited spectrum of activity, high application cost, or negative impact on 57 
the organoleptic quality of foods (Dufour et al., 2003). These limitations can, to an 58 
extent, be overcome by combinations of different antimicrobial agents (Zapico et al., 59 
1998; Branen and Davidson, 2004), combinations of antimicrobials with chelating 60 
agents (Stevens et al., 1991), or by the use of antimicrobials together with preservative 61 
treatments such as high hydrostatic pressure, low pH or freeze/thaw cycles (Roberts and 62 
Hoover, 1996; García-Graelis et al., 2000; Cressy et al., 2003). 63 
Nisin is a bacteriocin produced by Lactocococcus lactis spp. lactis that is 64 
primarily active against Gram-positive bacteria, and it has found practical application as 65 
a food preservative in a number of food products (Delves-Boughton et al., 1996). The 66 
practical application of nisin, however, is limited because its low stability, reduced 67 
activity at high pH and poor efficacy in certain food matrices (Pol et al., 2000). 68 
LF is a key element of the innate host defense system and, as such, it has crucial 69 
antimicrobial activities against a broad range of pathogens. In the case of bacteria, LF 70 
affects many Gram-positive and Gram-negative pathogens (reviewed in Valenti and 71 
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Antonini, 2005). In contrast, it seems to promote the growth of beneficial bacteria like 72 
Lactobacillus and Bifidobacteria (Sherman et al., 2004). The large-scale preparation of 73 
LF from cheese whey or skim milk makes it available for human and animal health 74 
purposes and commercial applications. LF also offers applications is food preservation 75 
and safety by limiting the growth of microbes. For example, incorporation of bovine LF 76 
into edible films has a great potential to enhance the safety of foods, or it can be also 77 
directly used as a spray applied to beef carcases (Taylor et al., 2004). 78 
Antimicrobial peptides derived from food proteins constitute a new field in the 79 
use of antimicrobial agents in food. Some of them have shown potent antimicrobial 80 
activity and a broad spectrum against Gram-positive and Gram-negative 81 
microorganisms. Antimicrobial peptides have been isolated from various food proteins 82 
but the greatest number described to date are from milk (for a recent review see López-83 
Expósito and Recio, 2006) or from chicken egg white (Pellegrini et al., 2004; Ibrahim et 84 
al., 2000). One of the most potent milk-derived antimicrobial peptides described so far 85 
corresponds to a fragment of the whey protein LF, named lactoferricin (Bellamy et al., 86 
1992), which possesses an antimicrobial potency against a wide range of 87 
microorganisms, which is ten-fold greater than that of the parent protein. Another 88 
peptide with a strong antimicrobial activity against Gram-positive and Gram-negative 89 
microorganisms is that corresponding to the bovine αs2-casein f(183-207). This 90 
fragment was obtained by hydrolysis of the bovine αs2-casein with pepsin (Recio and 91 
Visser, 1999b). Although only few works deal with the synergistic effect of LF with 92 
other antimicrobial compounds such as monolaurin, lysozyme or 93 
ethylenediaminetetraacetic acid (Branen and Davidson, 2004; Ellison and Giehl, 1991), 94 
to our knowledge, no synergism has been described among milk-derived peptides and 95 
nisin and LF. 96 
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The aim of this work was to study whether the peptides αs2-casein f(183-207) 97 
and LFcin-B can exert a synergistic effect in combination with other food proteins and 98 
peptides towards selected food-borne pathogens and spoilage bacteria. We intended to 99 
evaluate if these two antibacterial peptides were able to destabilize the outer membrane 100 
of Gram-negative microorganisms, in order to facilitate access of antimicrobial agents 101 
with a limited spectrum of activity against Gram-negative microorganisms such as LF 102 
and nisin. 103 
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MATERIAL AND METHODS 104 
 105 
Bacterial Strains and Growth Media  106 
Escherichia coli ATCC 25922 was from the American Type Culture Collection 107 
(ATCC) (Rockville, MD, USA), Listeria monocytogenes CECT 934, Staphylococcus 108 
epidermidis CECT 231, and Salmonella choleraesuis ssp. choleraesuis CECT 4594 109 
were from The Spanish Type Culture Collection (Colección Española de Cultivos Tipo, 110 
CECT; Valencia, Spain). Tryptic Soy Broth (TSB), Tryptic Soy Agar (TSA), Brain 111 
Heart Infusion Agar (BHIA) and Brain Heart Infusion (BHI) were from Scharlau, 112 
(Barcelona, Spain). Unless otherwise stated, all other chemicals were of the highest 113 
grade commercially available. 114 
 115 
Chemicals 116 
Bovine LF was kindly donated by Domo Food Ingredients (Beilen, The 117 
Netherlands). Iron content of the LF preparation was determined by inductively coupled 118 
plasma-optical emission spectrometry (Larrea et al., 1997). Nisin (2.5% nisin) was 119 
purchased from Sigma (St. Louis, MO; USA). 120 
 121 
αs2-casein f(183-207) and Bovine Lactoferricin Preparation 122 
Bovine αs2-casein f(183-207) was prepared by conventional Fmoc (Fluorenyl-123 
methoxy-carbonyl) solid-phase synthesis method with a 431 A peptide synthesiser 124 
(Applied Biosystems Inc., Überlingen, Germany) and purified after synthesis by semi-125 
preparative RP-HPLC with the conditions previously described by López-Expósito et al 126 
(2006a). 127 
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LFcin-B was prepared as previously described by Recio and Visser (1999a). 128 
Briefly, an LF hydrolysate (5% w/v) was prepared in acidified water (pH 3.0) with 3% 129 
(w/w) of porcine pepsin A (EC 3.4.23.1, 445 U/mg solid, from Sigma) for 4 h at  37ºC. 130 
The reaction was terminated by heating at 80ºC for 15 min and the pH was adjusted to 131 
7.0 by the addition of 1M NaOH. The supernatant obtained after centrifugation (16 000 132 
g for 15 min) was injected onto a column (150 ×26 mm I.D.) of SP-Sepharose Fast 133 
Flow resin (Pharmacia LKB Biotechnology, Uppsala, Sweden) equilibrated at 4ºC with 134 
ammonium hydrogen carbonate buffer acidified with formic acid to pH 7.0. Peptides 135 
were eluted with a flow rate of 5 ml/min with a gradient going from 0 to 100% in 70 136 
min of 5 M ammonia solution. Finally, the column was eluted with 2 M NaCl, and this 137 
fraction containing LFcin-B was desalted by a semi-preparative RP-HPLC step. The 138 
purity of the LFcin-B obtained was evaluated by RP-HPLC-MS as previously described 139 
(López-Expósito et al., 2006b). 140 
 141 
Antimicrobial Activity 142 
Antimicrobial activity was determined using CryoTubes™ Vials (Nunc™, 143 
Roskilde, Denmark). Single colonies of bacteria grown on TSA plates (E. coli, S. 144 
choleraesuis and St. epidermidis) or BHIA plates (L. monocytogenes) were inoculated 145 
with 10 mL of TSB or BHI and grown overnight at 37ºC. A total of 300 µL of bacterial 146 
suspension was diluted 1/50 with TSB or BHI. Bacteria were grown at 37ºC and 147 
logarithmic phase organisms were harvested at a density of 1-4 × 108 colony forming 148 
units (cfu)/mL. The culture was then centrifuged at 2000 × g for 10 min. Bacteria were 149 
washed twice with 10 mM Na-phosphate buffer, pH 7.4, and adjusted to 105 cfu/mL 150 
approximately. A total of 50 µL of the bacterial suspension were mixed with 50 µL of 151 
the antimicrobial sample to be investigated together with 100 µL of 2% TSB or BHI in 152 
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10 mM phosphate buffer pH 7.4 and with 800 μL of 10 mM phosphate buffer pH 7.4. 153 
The mixture was incubated at 37ºC for 2 h with agitation and then plated on TSA or 154 
BHIA plates. The plates were incubated at 37ºC (E. coli, S. cholerasuis, St. epidermidis) 155 
or 30ºC (L. monocytogenes) for 24 h before the colonies were counted. The assays were 156 
conducted in triplicate. The antimicrobial activity was expressed as the concentration of 157 
antimicrobial agent that gave a log (N0/Nf) value between 0.25 and 0.5. 158 
 159 
Evaluation of Synergy 160 
To determine antimicrobial interactions, a synergy index was defined based on 161 
fractional inhibitory concentration-index previously described by Davidson and Parish 162 
(1989). The synergy index of an individual antimicrobial compound is the ratio of the 163 
concentration of the antimicrobial compound in an inhibitory combination with a 164 
second compound to the concentration of the antimicrobial by itself as follows: 165 
IndexA = (Activity of A with B)/Activity of A 166 
The synergy index was calculated as follows with the indices for the individual 167 
antimicrobials: Synergy Index = IndexA + IndexB. If the synergy index is <1, the 168 
interaction is considered to be synergistic, if the synergy index = 1 the interaction is 169 
additive, and an synergy index >1 represents antagonism between two substances. 170 
 171 
RESULTS AND DISCUSSION 172 
 173 
Determination of the antibacterial activity 174 
The antibacterial activity of the protein and peptides under investigation was 175 
determined against two Gram-negative and two Gram-positive bacterial strains, and the 176 
results are shown in Table 1. The lantibiotic nisin was active against both Gram-177 
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negative and Gram-positive bacteria although against the Gram-negative 178 
microorganisms it showed notably lower activity than against the Gram-positive ones. 179 
Nisin is an antimicrobial compound with a spectrum limited essentially to Gram-180 
positive microorganisms. Our results showed that nisin could also exert certain 181 
antimicrobial activity against Gram-negative bacteria, confirming the results reported by 182 
Kuwano et al. (2005). The disparities found by different authors are probably due to the 183 
conditions of the antibacterial assay. In any case, the results reported in Table 1 show 184 
that to reveal some appreciable antibacterial activity against Gram-negative bacteria, 185 
nisin must be assayed at least at a concentration 10 times higher than against Gram-186 
positive bacteria. 187 
 LF was active against both Gram-negative and Gram-positive bacteria. The LF 188 
preparation used in this study contained 198 ± 5 µg of iron/g of dry weight as 189 
determined by elemental analysis (i.e., approximately 13.6% saturation, considering 2 190 
metal binding sites per 77 000 Da) The antibacterial activity values ranged from 0.075 191 
μM against E. coli to 2.5 μM against St. epidermidis. In fact, regarding Gram-negative 192 
bacteria, LF was strongly active against E. coli and to a lesser extent against S. 193 
choleraesuis. Among Gram-positive bacteria, L. monocytogenes was highly sensitive to 194 
LF, whereas St. epidermidis was only weakly affected by the action of this protein. 195 
Thus, the differences observed cannot be easily explained in terms of a different 196 
composition of the bacterial membrane. These results are in agreement with previous 197 
studies with human LF where non-enteropathogenic strains of E. coli were classified as 198 
LF-sensitive strains and St. epidermidis was relative resistant to the effect of apo-LF 199 
(Arnold et al., 1980). The peptide fragment of LF, LFcin-B, was active against both 200 
Gram-negative and Gram-positive bacteria. Its antibacterial activity was stronger than 201 
that of its parent protein confirming the results reported by other authors (Bellamy et al., 202 
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1992). As shown in Table 1, similar activity was previously found for Lfcin-B against 203 
E. coli and St. epidermidis (Jones et al.,1994). 204 
The peptide f(183-207) derived from αs2-casein was active against both Gram-205 
negative and Gram-positive bacteria. However, similarly to LF, notable differences 206 
were observed in the bactericidal activity against the strains investigated. L. 207 
monocytogenes was the strain most sensitive to the action of f(183-207) whereas St. 208 
epidermidis was the least. 209 
 210 
Interactions Between LFcin-B and other Antimicrobial Compounds 211 
In order to investigate a possible synergistic effect between LFcin-B and LF or 212 
nisin against E. coli and St. epidermidis, synergy indices were calculated. Results are 213 
shown in Table 2. From the results obtained, it must be highlighted that LF and the LF-214 
derived peptide, LFcin-B, acted synergistically against E. coli and St. epidermidis. 215 
LFcin-B and LF displayed against E. coli activity values of 0.0125 and 0.075 µM, 216 
respectively, whereas the activity value decreased to 0.0075 µM when they were 217 
assayed together. The synergy index determined for the combination LF and LFcin-B 218 
against E. coli and St. epidermidis was 0.68 and 0.51, respectively (Table 2). The LF 219 
and LFcin-B used in this study were of bovine milk but if this synergism could also be 220 
demonstrated with LFcin and LF from human origin, it could have physiological 221 
implications. It has been demonstrated by mass spectrometry that significant amounts of 222 
fragments that contain LFcin-B are produced in human stomach following ingestion of 223 
LF, and therefore, functional quantities of human LFcin might be generated in the 224 
human stomach (Kuwata et al., 1998a). LFcin has also been detected in the 225 
gastrointestinal tract of adult mice (Kuwata et al., 1998b). In the same way, it was 226 
demonstrated that a portion of ingested LF is incompletely hydrolyzed (Spik et al., 227 
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1982) and the concentration of LF in human milk is approximately 2 g/L in mature milk 228 
(Lönnerdal, 2003) and 7 g/L in human colostrum (Ward and Connelly, 2004). It is, 229 
therefore, likely that LF and LFcin coexist in the gastrointestinal tract of the breast-fed 230 
infants and these compounds could act synergistically, increasing the host´s defences 231 
against invading microorganisms. 232 
When LFcin-B was combined with nisin, an antagonistic effect was found 233 
against E.coli (FIC-index of 4.02), while the synergy index achieved against St. 234 
epidermidis revealed an additive interaction (synergy index of 1.0). This antagonistic 235 
effect was also previously reported when nisin was combined with reuterin against 236 
Gram-negative microorganisms (Arqués et al., 2004a).  237 
 238 
Interactions Between Bovine αs2-casein f(183-207) and other Antimicrobial 239 
Compounds 240 
As shown in Table 2, the synergy indices obtained with the αs2-casein peptide 241 
combined with LF and nisin revealed a synergistic effect against St. epidermidis 242 
Particularly efficient were the combinations of the αs2-casein peptide with LF and nisin 243 
against St. epidermidis, with synergy values of 0.02 and 0.1, respectively. These low 244 
indices indicate a strong synergism of these two combinations. As can be observed from 245 
Figure 1, when both substances were tested alone, concentrations of 10 μM of LF and 5 246 
μM of the αs2-casein peptide were required to reach the maximum growth inhibition. 247 
When the combination of LF and the αs2-casein peptide was assayed, a concentration of 248 
2.5 µM of each compound was enough to obtain the same effect. If the αs2-casein 249 
peptide could be generated upon enzymatic hydrolysis in the suckling gastrointestinal 250 
tract, this synergism might also have a physiological meaning as both compounds could 251 
coexist in the gastrointestinal tract of a breast fed infant. On the other hand, the synergy 252 
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between αs2-casein f(183-207) and nisin could find some application in the food 253 
industry where nisin is already used as a food preservative. Other authors have obtained 254 
a synergistic interaction by combining nisin with monolaurin (Mansour and Millière, 255 
2001), garlic extract (Singh et al., 2001), lactoperoxidase system (Zapico, et al., 1998) 256 
or reuterin (Arqués et al., 2004b), but to date, the interaction of nisin with other milk-257 
proteins and peptides has not been attempted. Against E.coli, only the combination of 258 
the casein-derived peptide with LF demonstrated a synergistic interaction, while 259 
combination with nisin had an antagonistic effect. It had been previously reported that 260 
LF in combination with monolaurin inhibited growth of E. coli O157:H7 but not E. coli 261 
O104:H21 (Branen and Davidson, 2004) and therefore, this synergistic behavior should 262 
be confirmed with other E. coli strains.  263 
 264 
Bovine αs2-Casein f(183-207) Interactions Against Food-Borne Pathogens 265 
 Combinations with synergy indices lower than 0.5 were also assayed against the 266 
food-borne pathogens Salmonella choleraesuis and Listeria monocytogenes. The results 267 
obtained for the combinations of αs2-casein f(183-207) with LF and nisin are shown in 268 
Table 2. These two combinations were synergistic against L. monocytogenes but had an 269 
antagonistic effect when tested against E. coli. Of special interest was the combination 270 
of the peptide from αs2-casein with nisin, because of the ability of L. monocytogenes to 271 
develop resistance to nisin (Davies and Adams, 1994). Probably, the peptide αs2-casein 272 
f(183-207) could destabilize the bacterial membrane, making this microorganism more 273 
susceptible to the action of nisin. Therefore, as indicated above, the combination of αs2-274 
casein f(183-207) and nisin could be of use in the food industry as a food preservative. 275 
In relation to S. choleraesuis, none of the combinations assayed were synergistic 276 
against this bacterium. The synergy index was 1.75 for the combination with LF and 277 
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5.50 for the combination with nisin (Table 3). The reason why these two combinations, 278 
casein-derived peptide with LF or nisin, were synergistic against the Gram-positive 279 
bacteria (St. epidermidis and L. monocytogenes) but not against Gram-negative bacteria 280 
(E. coli and S. choleraesuis) is not clear. It may be due to the more complex membrane 281 
structure of Gram-negative bacteria. However, combinations of LF with LFcin-B or 282 
with the casein-derived peptide exerted a synergistic effect against E. coli. It has been 283 
postulated that differences in the antibacterial action of EDTA-nisin combinations 284 
against different Gram-negative bacteria could be attributed to differences in the outer 285 
membrane or LPS structure which may affect the amount of LPS released from the 286 
outer membrane and the resulting increase in permeability (Branen and Davidson, 287 
2004). 288 
 289 
CONCLUSIONS 290 
The antimicrobial activity of LF and nisin can be enhanced by simultaneous 291 
addition of the peptides LFcin-B and αs2-casein f(183-207). More specifically, these 292 
two peptides have been demonstrated to act synergistically or additively with LF and 293 
nisin against the Gram-positive microorganism St. epidermidis. However, against 294 
Gram-negative E. coli, only the combination of these two peptides with LF have proved 295 
to be more effective at inhibiting bacterial growth than either agent used alone. Peptide 296 
αs2-casein f(183-207) synergistically enhanced the activity of nisin and LF against L. 297 
monocytogenes. Some of these combinations, such as LF with LFcin-B or LF with αs2-298 
casein f(183-207) may be relevant for the host defense properties of LF. The results 299 
obtained in this work further highlight the potential of using nisin in combination with 300 
αs2-casein f(183-207) to improve its effectiveness at inhibiting Listeria monocytogenes. 301 
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Although results obtained in growth media cannot be directly extrapolated to food 302 
matrices, this combination may, therefore, be promising for use in food preservation. 303 
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Figure captions 413 
Figure 1. Antibacterial activity at different concentrations of (?) lactoferrin (?) αs2-414 
casein f(183-207) (?) lactoferrin + αs2-casein f(183-207) against Staphylococcus 415 
epidermidis CECT 231 growth in tryptic soy broth. Antibacterial activity was calculated 416 
as log N0/Nf. Where N0 refers to the control number of colonies without antibacterial 417 
material (103 cfu/mL) and Nf refers to the number of colonies containing antibacterial 418 
compounds after an incubation period of 2 h at 37ºC. 419 
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Table 1. Antibacterial activity expressed as the concentration (μM) of antimicrobial 432 
agent that gave a log (N0/Nf) value between 0.25 and 0.5 against different Gram-433 
negative (Escherichia coli, Salmonella choleraesuis) and Gram-positive 434 
(Staphylococcus epidermidis, Listeria monocytogenes).microorganisms for each 435 
antimicrobial agent evaluated. 436 
 437 
 438 
 439 
 440 
 441 
 442 
 443 
n.d: not determined 444 
Molecular masses considered were 77000 for lactoferrin, 3475 for nisin; 3115 for αs2-445 
casein f(183-207), and 3125 for bovine lactoferricin. 446 
Antimicrobial Microorganisms 
 Gram-negative Gram-positive 
 
 E. coli S. choleraesuis St. epidermidis L. monocytogenes 
LF 0.075 1.25 2.500 0.25 
Nisin 0.500 5.00 0.050 0.25 
f(183-207) 1.250 0.5 2.500 0.05 
LFcin-B 0.0125 n.d 0.050 n.d 
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Table 2. Antibacterial activity expressed as the concentration (μM) of antimicrobial 447 
agent that gave a log (N0/Nf) value between 0.25 and 0.5, and synergy indexes (index) 448 
for each combination assayed against Escherichia coli ATCC 25922 and 449 
Staphylococcus epidermidis. Combinations of αs2-casein f(183-207) with lactoferrin (LF) 450 
and nisin were also assayed against Salmonella choleraesuis and Listeria monocytogenes. 451 
 452 
Antimicrobial Microorganisms 
 Escherichia coli Staphylococcus epidermidis 
LFcin-B with Activity Index Effect Activity Index Effect 
LF 0.0075 0.68 Synergism 0.0025 0.51 Synergism 
Nisin 0.0500 4.02 Antagonism 0.0250 1.00 Additive 
αs2-casein f(183-207) with Activity Index Effect Activity Index Effect 
LF 0.025 0.35 Synergism 0.0250 0.02 Synergism 
Nisin 2.500 7.00 Antagonism 0.0050 0.10 Synergism 
 Salmonella choleraesuis Listeria monocytogenes 
αs2-casein f(183-207) with Activity Index Effect Activity Index Effect 
LF 2.5 1.75 Antagonism 0.0025 0.60 Synergism 
Nisin 0.0625 5.50 Antagonism 0.0025 0.60 Synergism 
